E-LIB Suche - Ergebnisse für: Gagliardini, Roberta

1

Rapid ART initiation with bictegravir/emtricitabine/tenofov..:

Camici, Marta ; Gagliardini, Roberta ; Lanini, Simone...
International Journal of Antimicrobial Agents. 63 (2024) 1 - p. 107049 , 2024

Link: https://doi.org/10.1016/..

2

JN.1 neutralizing antibody titers after XBB.1.5 monovalent ..:

Matusali, Giulia ; Mazzotta, Valentina ; Meschi, Silvia...
Journal of Medical Virology. 96 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

3

Poor durability of the neutralizing response against XBB su..:

Matusali, Giulia ; Vergori, Alessandra ; Cimini, Eleonora...
Journal of Medical Virology. 96 (2024) 4 - p. , 2024

Link: https://doi.org/10.1002/..

4

Immunogenicity and reactogenicity of modified vaccinia Anka..:

Mazzotta, Valentina ; Lepri, Alessandro Cozzi ; Matusali, Giulia...
eClinicalMedicine. 68 (2024) - p. 102420 , 2024

Link: https://doi.org/10.1016/..

5

Pharyngo-tonsillar involvement of Mpox in a cohort of men w..:

Pinnetti, Carmela ; Mondi, Annalisa ; Mazzotta, Valentina...
Journal of Infection and Public Health. 17 (2024) 1 - p. 130-136 , 2024

Link: https://doi.org/10.1016/..

6

Human and Viral microRNA Expression in Acute and Chronic HI..:

Lazzari, Elisabetta ; Rozera, Gabriella ; Gagliardini, Roberta...
Viruses. 16 (2024) 4 - p. 496 , 2024

Link: https://doi.org/10.3390/..

7

Impact of COVID-19 pandemic on retention in care of native ..:

Gagliardini, Roberta ; Giacomelli, Andrea ; Bozzi, Giorgio...
Travel Medicine and Infectious Disease. 58 (2024) - p. 102691 , 2024

Link: https://doi.org/10.1016/..

8

Characterization and outcomes of difficult-to-treat patient..:

Gagliardini, Roberta ; Tavelli, Alessandro ; Rusconi, Stefano...
International Journal of Antimicrobial Agents. 63 (2024) 1 - p. 107018 , 2024

Link: https://doi.org/10.1016/..

9

Polypharmacy, anticholinergic burden and drug–drug interact..:

Mazzitelli, Maria ; Pontillo, Domenico ; Clemente, Tommaso...
Journal of Antimicrobial Chemotherapy. 79 (2024) 9 - p. 2163-2169 , 2024

Link: https://doi.org/10.1093/..

10

Cohort profile: PRESTIGIO, an Italian prospective registry-..:

Clemente, Tommaso ; Galli, Laura ; Lolatto, Riccardo...
BMJ Open. 14 (2024) 2 - p. e080606 , 2024

Link: https://doi.org/10.1136/..

11

SARS-CoV-2 mRNA vaccination and short-term changes in viral..:

Vergori, Alessandra ; Cozzi-Lepri, Alessandro ; Tavelli, Alessandro...
International Journal of Infectious Diseases. 144 (2024) - p. 107065 , 2024

Link: https://doi.org/10.1016/..

12

HIV-1 RNA monitoring with a dual-target diagnostic assay: A..:

Sberna, Giuseppe ; Gagliardini, Roberta ; Rozera, Gabriella...
Heliyon. 10 (2024) 9 - p. e29842 , 2024

Link: https://doi.org/10.1016/..

13

Pharmacokinetics of tecovirimat in subjects with Mpox:

Tempestilli, Massimo ; Mondi, Annalisa ; D'Avolio, Antonio...
International Journal of Antimicrobial Agents. 63 (2024) 2 - p. 107068 , 2024

Link: https://doi.org/10.1016/..

14

HIV-1 transmitted drug resistance in newly diagnosed indivi..:

Fabeni, Lavinia ; Armenia, Daniele ; Abbate, Isabella...
Journal of Antimicrobial Chemotherapy. 79 (2024) 9 - p. 2152-2162 , 2024

Link: https://doi.org/10.1093/..

15

Mpox as AIDS-defining event with a severe and protracted co..:

Pinnetti, Carmela ; Cimini, Eleonora ; Mazzotta, Valentina...
The Lancet Infectious Diseases. 24 (2024) 2 - p. e127-e135 , 2024

Link: https://doi.org/10.1016/..